advertisement

WGA Rescources

Das S 10

Showing records 1 to 10 | Display all abstracts from Das S

106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Patel V
Cureus 2022; 14: e29286
106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Nivean PD; Ariga M
Indian Journal of Ophthalmology 2022; 70: 4164-4167
106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Freedman RL; Freedman RL; Freedman RL
Cureus 2022; 14: e29286
106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Chithra MR
Indian Journal of Ophthalmology 2022; 70: 4164-4167
106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Das S
Cureus 2022; 14: e29286
106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Gohil P
Indian Journal of Ophthalmology 2022; 70: 4164-4167
106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Mansoor S
Cureus 2022; 14: e29286
106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Das S
Indian Journal of Ophthalmology 2022; 70: 4164-4167
106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Parekh H; Ridha F
Cureus 2022; 14: e29286
106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Jaideep G
Indian Journal of Ophthalmology 2022; 70: 4164-4167

Issue 23-3

Change Issue


advertisement

Oculus